Table 2.
Clinical features of patients in COVID-19 and non-COVID-19
| Feature | Non-COVID-19 (n = 66) | COVID-19 (n = 70) | p value |
|---|---|---|---|
| Sex | |||
| Male# | 43 (65.15%) | 41 (58.57%) | 0.430a |
| Female# | 23 (34.85%) | 29 (41.43%) | |
| Age (years) | 46.73 ± 25.00 | 42.93 ± 13.32 | 0.275b |
| Vital signs | |||
| Systolic blood pressure (mmHg) | 126.92 ± 23.07 | 127.07 ± 15.16 | 0.965b |
| Diastolic blood pressure (mmHg) | 77.74 ± 15.72 | 80.39 ± 10.51 | 0.254b |
| Respiration rate (bpm) | 25.20 ± 7.29 | 19.86 ± 1.90 | < 0.001b* |
| Heart rate (bpm) | 101.59 ± 20.36 | 86.06 ± 13.34 | < 0.001b* |
| Temperature (°C) | 37.61 ± 1.06 | 37.12 ± 0.83 | 0.003b* |
| Signs | |||
| Dry cough# | 56 (84.85%) | 48 (68.57%) | 0.025a* |
| Fatigue# | 8 (12.12%) | 22 (31.43%) | 0.007a* |
| Sore throat# | 6 (9.09%) | 9 (12.86%) | 0.483a |
| Stuffy# | 4 (6.06%) | 2 (2.86%) | 0.623a |
| Runny nose# | 3 (4.55%) | 3 (4.29%) | 0.731a |
| White blood cell count (× 109/L) | 11.48 ± 5.36 | 5.27 ± 2.33 | < 0.001b* |
| White blood cell count category | < 0.001c* | ||
| Low# | 0 (0.00%) | 2 (2.86%) | |
| Normal# | 27 (40.91%) | 63 (90.00%) | |
| High# | 39 (59.09%) | 5 (7.14%) | |
| Lymphocyte count (× 109/L) | 1.57 ± 1.33 | 1.25 ± 0.68 | 0.086b |
| Lymphocyte count category | < 0.001c* | ||
| Low# | 24 (36.36%) | 32 (45.71%) | |
| Normal# | 35 (53.03%) | 37 (52.86%) | |
| High# | 7 (10.61%) | 1 (1.43%) | |
| Neutrophil count (× 109/L) | 8.97 ± 4.90 | 3.53 ± 2.17 | < 0.001b* |
| Neutrophil count category | < 0.001c* | ||
| Low# | 3 (4.55%) | 8 (11.43%) | |
| Normal# | 23 (34.85%) | 59 (84.29%) | |
| High# | 40 (60.61%) | 3 (4.29%) | |
| C-reactive protein (mg/L) | 69.30 ± 65.88 | 26.37 ± 30.97 | < 0.001b* |
| Procalcitonin (ng/mL) | 3.36 ± 8.98 | 0.26 ± 0.84 | 0.007b* |
*Data with statistical significance. pa: chi-square test, pb: Student’s t test. pc: Kruskal-Wallis H test
#Results are measurements with corresponding ratio in parentheses